HB 1530, the Genetic Information Privacy Act, requires direct-to-consumer genetic testing companies operating in Pennsylvania to protect residents' genetic data. Companies must obtain clear, separate consent for data collection, use, sharing, and retention; implement security measures; and provide consumers with access to or deletion of their data. The bill specifically prohibits sharing genetic data with insurers, employers, or third parties without explicit written consent. Violations could result in $2,500 civil penalties per incident, enforced by the Attorney General’s office. The law applies to Pennsylvania residents and covers genetic data like DNA test results, but excludes research data collected under federal health privacy rules.
HB 923 amends the State Lottery Law to redirect lottery revenue toward providing pharmaceutical assistance for elderly residents. It directly affects seniors who qualify for prescription drug aid under state programs by modifying eligibility determination procedures. The key provision updates how income and asset thresholds are calculated to determine who qualifies for this assistance. The bill became law on November 24, 2025, after approval by both legislative chambers and the governor.
SB 88 amends Pennsylvania's Insurance Company Law to require health insurance plans sold in the state to cover specific breast imaging services without cost-sharing for policyholders. It mandates annual mammograms for women 40+ and physician-recommended mammograms for women under 40, plus MRI and other breast imaging for those at average or higher risk of breast cancer due to factors like family history, genetic mutations, or dense breast tissue. The law specifies coverage for screening, supplemental, and diagnostic exams but does not require coverage for mastectomies or override standard deductibles/copays beyond the minimum required services. This replaces prior requirements that allowed cost-sharing and excluded MRI coverage.
SB 731 amends the existing Pharmaceutical Assistance Contract for the Elderly (PACE) program to add a new "Needs Enhancement Tier" for determining eligibility. This tier would allow more elderly residents to qualify for prescription drug assistance based on specific financial or health needs. The bill changes how eligibility is assessed under the program, making it easier for seniors with higher needs to access medication support. The bill recently passed final passage on November 12, 2025, and is now referred to Rules & Executive Nominations.
HB 416 establishes a new Child Care Staff Recruitment and Retention Program to support early childhood educators and creates a Rural Health Transformation Program to improve healthcare access in underserved areas. It also streamlines permit processes for economic development projects through the Streamlining Permits for Economic Expansion and Development Program. These provisions are integrated into the 2025 state budget implementation, alongside administrative updates to tax collection procedures, state fund management, and reporting requirements for agencies like the Department of Revenue and Treasury. The bill does not alter existing tax rates or create new funding streams but modifies how current state financial systems operate.
HB 749 updates Pennsylvania's public welfare laws to streamline assistance programs and improve service access. It requires copayments for subsidized child care, changes reporting for SNAP benefits, and mandates reports on transitioning to chip-enabled access cards for benefits. The bill removes regulatory barriers for outpatient behavioral health services provided within clinic facilities, allowing services to be billed as part of the clinic visit. It also requires additional reports to the General Assembly regarding medical assistance eligibility and nonemergency medical transportation services.
HB 446 requires hospitals and ambulatory surgical facilities in Pennsylvania to offer patients unused, facility-provided medication at no additional cost upon discharge, if the prescriber determines it's clinically appropriate for continuing treatment. The bill specifies that this applies only to non-controlled, multi-dose medications like eye drops, creams, or inhalers (excluding IV drugs or controlled substances), and mandates clear discharge instructions with usage details and contact information. Providers acting in good faith are protected from liability for patient misuse, and such medication offers are exempt from standard outpatient dispensing rules. This directly affects patients discharged from hospitals or ambulatory facilities and the healthcare facilities providing their care.
HB 1974 creates a new Contingency Management Support Grant Program within the Department of Drug and Alcohol Programs. The bill establishes a mechanism for distributing grants to support substance use disorder treatment programs that use evidence-based contingency management approaches (like providing rewards for treatment adherence). This program directly affects licensed treatment providers and individuals receiving substance use disorder services by providing funding for these specific support services. The bill amends the 1929 Administrative Code to authorize this grant program under the department's existing authority.
HB 157 creates state grants to help healthcare entities in rural counties or designated medically underserved areas cover the student loan debt of their employed healthcare practitioners. The grants would be paid directly to the healthcare facilities (like clinics or hospitals), not to individual providers, to offset the cost of practitioners' education debt. This aims to support recruitment and retention of healthcare workers in areas with limited access to medical services. The program would be funded through state appropriations, targeting facilities serving communities with significant healthcare access challenges.
HB 1212 requires Pennsylvania maternal health programs to provide drug screening and awareness education to patients. It also mandates the inclusion of fatherhood engagement strategies in prenatal care discussions, directly affecting pregnant individuals and their partners receiving maternal health services. The bill imposes specific duties on the Joint State Government Commission to develop and oversee these program requirements. These provisions aim to integrate substance use prevention and family involvement into standard maternal health care protocols.
